← Eichor
Condition: Immune Mediated Hepatitis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Immune Mediated Hepatitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Management of Immune Checkpoint Inhibition-related Hepatitis Using Low-dose Corticosteroids
Phase N/A · 2 location(s) · University Hospital, Basel, Switzerland · NCT07167251Checkpoint Inhibitor-induced Liver Injury
Phase N/A · 1 location(s) · University of Nottingham · NCT04476563Specific Biomarkers of Immune-mediated Hepatitis Secondary to Immune Checkpoint Inhibitors
Phase N/A · 1 location(s) · University Hospital, Montpellier · NCT06470997Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCC
NA · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT05484908
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.